$MNKD Recent Headlines 3 overlooked stocks lov
Post# of 94279
Posted On: 06/04/2014 6:48:13 PM
$MNKD Recent Headlines
3 overlooked stocks loved by top-ranked advisers 3:09 p.m. April 25, 2014 - Mark Hulbert
Tesla, Facebook seesaw; Questcor surges on deal 3:54 p.m. April 7, 2014 - Sue Chang
MannKind drops after FDA says its review on drug will last until July 1:46 p.m. April 7, 2014 - Russ Britt
Stock futures drop as earnings season looms 9:20 a.m. April 7, 2014 - Sara Sjolin
MannKind drops 12% after FDA review extension 7:15 a.m. April 7, 2014 - Ben Eisen
MannKind drops 16% after FDA review extension 7:01 a.m. April 7, 2014 - Ben Eisen
U.S. stocks up; S&P 500 hits record 9:15 a.m. April 3, 2014 - Anora Mahmudova
MannKind soars on drug recommendation; Apollo slumps 4:13 p.m. April 2, 2014 - Sue Chang
Myriad shares soar after Medicare reimbursements get a 37% boost 1:44 p.m. April 2, 2014 - Russ Britt
MannKind shares nearly double after FDA panel OKs insulin treatment 10:40 a.m. April 2, 2014 - Russ Britt
Stock futures pare gains after ADP 8:59 a.m. April 2, 2014 - Barbara Kollmeyer
MannKind: FDA committee recommends Afreeza OK 7:14 a.m. April 2, 2014 - MarketWatch.com
MannKind soars 97% after FDA panel nod for Afrezza 7:14 a.m. April 2, 2014 - Barbara Kollmeyer
Apollo shares slip after revenue falls short 6:54 p.m. April 1, 2014 - Wallace Witkowski
7 gut checks before the stock market's opening bell 6:25 a.m. Aug. 15, 2013 - Shawn Langlois
On a mixed day, two biopharma firms' insulin drugs vie for investors 11:41 a.m. June 19, 2013 - Russ Britt
MannKind shares leap as web site says firm is a ripe takeover target 1:32 p.m. May 22, 2013 - Russ Britt
MannKind up 6.9% in premarket 8:43 a.m. Jan. 2, 2013 - Steve Gelsi
MannKind prices offering at 23% discount 10:04 a.m. Oct. 18, 2012 - MarketWatch.com
MannKind down 25% in premarket 8:59 a.m. Oct. 18, 2012 - Steve Gelsi
MannKind continues its bull run 12:16 p.m. Today - Seeking Alpha
MannKind (MNKD) Surges to 52-Week High as Afrezza Approval Approaches 11:58 a.m. Today - TheStreet.com
Hottest Healthcare Stocks Now – EXAS MNKD KERX MYGN 8:00 a.m. Today - InvestorPlace.com
As Predicted, MannKind Starting Emotionally Fueled Run To FDA Approval, When It May Be Best To Go Short 8:59 a.m. June 3, 2014 - Seeking Alpha
MannKind (MNKD) at Jefferies Global Healthcare Conference (Transcript) 7:25 p.m. June 2, 2014 - Seeking Alpha
MannKind's (MNKD) Management Presents at Jefferies Global Healthcare Conference (Transcript) 7:25 p.m. June 2, 2014 - Seeking Alpha
5 Stocks With Poor Sales Growth — HTS MITT LPCN MNKD UEC 10:00 a.m. June 2, 2014 - InvestorPlace.com
The IBB Likely To Move Higher Along With These Biotechs With Catalysts Upcoming 8:30 a.m. June 2, 2014 - Seeking Alpha
Biggest Movers in Healthcare Stocks Now – MNKD LCI RDY NBIX 7:45 a.m. May 30, 2014 - InvestorPlace.com
The Seven Deadly Sins of Biotech Investing 7:00 a.m. May 29, 2014 - TheStreet.com
Hottest Healthcare Stocks Now – HZNP MNKD BSX ISIS 1:45 p.m. May 28, 2014 - InvestorPlace.com
Short MannKind On Afrezza Approval? 3:33 p.m. May 27, 2014 - Seeking Alpha
MannKind Annual Shareholder Meeting Provides Further Optimism For Afrezza And Technosphere Platform 3:05 p.m. May 27, 2014 - Seeking Alpha
One Small Step For Afrezza, One Huge Step For MannKind? 10:44 a.m. May 27, 2014 - benzinga.com
2nd Half Of 2014 Biotechnology Catalysts: Part 1 9:34 a.m. May 27, 2014 - Seeking Alpha
Biotech Stock Roundup: Celldex, Incyte Tie Up with Big Pharma for Immuno-Oncology - Analyst Blog 9:22 a.m. May 21, 2014 - Zacks.com
Hottest Healthcare Stocks Now – CLVS CYH AZN MNKD 9:00 a.m. May 20, 2014 - InvestorPlace.com
MannKind: Approval For Afrezza Looking More And More Positive As Investors Await FDA Decision 10:03 a.m. May 19, 2014 - Seeking Alpha
Hottest Healthcare Stocks Now – ICLR PRXL MNKD SGEN 6:15 a.m. May 19, 2014 - InvestorPlace.com
Twelve Analyst Stocks to Buy Under $10 for Big Upside 8:35 a.m. May 17, 2014 - 247WallSt.com
MannKind to Present at Upcoming Conferences 9:01 a.m. May 27, 2014 - GlobeNewswire
Reveal Insider Trading for Facebook, MannKind, QUALCOMM, American Realty Capital Properties, salesforce.com, and Symantec 8:55 a.m. May 22, 2014 - PR Newswire - PRF
Technical Data on Top Gainers -- Research on MannKind, Intermolecular, FireEye, and Yingli Green Energy Holding 9:10 a.m. May 20, 2014 - PR Newswire - PRF
Earnings Release Results, and Leadership Appointments - Analyst Notes on Halozyme, MannKind, Arrowhead, Idera and BioCryst 7:00 a.m. May 16, 2014 - PR Newswire - PRF
Critical Alerts For Citigroup, Linn Energy, MannKind, Canadian Solar, and Qualcomm Released By InvestorsObserver 9:31 a.m. May 15, 2014 - PR Newswire - PRF
MannKind Corporation Pending FDA Approval Inspires Analyst Report by BrokerBank Securities, Inc. 8:00 a.m. May 14, 2014 - PR Newswire - PRF
MannKind Corporation Reports 2014 First Quarter Financial Results 9:01 a.m. May 12, 2014 - GlobeNewswire
MannKind to Present at Bank of America Merrill Lynch 2014 Health Care Conference 5:01 p.m. May 7, 2014 - GlobeNewswire
MannKind Corporation to Hold 2014 First Quarter Financial Results Conference Call on May 12, 2014 9:01 a.m. May 5, 2014 - GlobeNewswire
Active Stocks Technical Review -- Research on AES Corp., Baidu, Hertz Global Holdings, and MannKind 1:01 p.m. April 30, 2014 - PR Newswire - PRF
Abattis Bioceuticals Corp. Enters Into Share Agreement with Experion 10:00 a.m. April 17, 2014 - ACCESSWIRE
Elite Pharmaceuticals to Receive up to 40 Million from Lincoln Park Capital Fund 10:01 a.m. April 15, 2014 - ACCESSWIRE
Critical Alerts For Walt Disney, Walgreen, BioMarin Pharmaceuticals, Canadian Solar, and MannKind Released By InvestorsObserver 9:31 a.m. April 14, 2014 - PR Newswire - PRF
FDA Recommendations, Study Publications, Recognitions, Agreements, and Acquisitions - Analyst Notes on MannKind, Acceleron, Steris, Retrophin, and NxStage Medical 8:00 a.m. April 11, 2014 - PR Newswire - PRF
Petr Announces Well Online and Estimates 26,000 Barrels of Oil per Day; MannKind's Afressa Drug Decision Extended by the FDA 1:05 a.m. April 8, 2014 - ACCESSWIRE
MannKind Updates Status of New Drug Application for AFREZZA(R) 4:00 a.m. April 7, 2014 - GlobeNewswire
Pre-Market Review on Top Gainers -- Research on MannKind, ZBB Energy, B2Gold, and DFC Global 9:08 a.m. April 3, 2014 - PR Newswire - PRF
Insider Trading Alert - Free Research of General Motors, Apple, RF Micro Devices, MannKind, Sirius XM, and Plug Power 8:55 a.m. April 3, 2014 - PR Newswire - PRF
FDA Panel Grants Market Approval of MannKind Corp.'s Inhalable Insulin 9:49 a.m. April 2, 2014 - ACCESSWIRE
FDA Advisory Committee Recommends Approval of AFREZZA(R), MannKind Corporation's Investigational Drug to Treat Diabetes 5:47 p.m. April 1, 2014 - GlobeNewswire
3 overlooked stocks loved by top-ranked advisers 3:09 p.m. April 25, 2014 - Mark Hulbert
Tesla, Facebook seesaw; Questcor surges on deal 3:54 p.m. April 7, 2014 - Sue Chang
MannKind drops after FDA says its review on drug will last until July 1:46 p.m. April 7, 2014 - Russ Britt
Stock futures drop as earnings season looms 9:20 a.m. April 7, 2014 - Sara Sjolin
MannKind drops 12% after FDA review extension 7:15 a.m. April 7, 2014 - Ben Eisen
MannKind drops 16% after FDA review extension 7:01 a.m. April 7, 2014 - Ben Eisen
U.S. stocks up; S&P 500 hits record 9:15 a.m. April 3, 2014 - Anora Mahmudova
MannKind soars on drug recommendation; Apollo slumps 4:13 p.m. April 2, 2014 - Sue Chang
Myriad shares soar after Medicare reimbursements get a 37% boost 1:44 p.m. April 2, 2014 - Russ Britt
MannKind shares nearly double after FDA panel OKs insulin treatment 10:40 a.m. April 2, 2014 - Russ Britt
Stock futures pare gains after ADP 8:59 a.m. April 2, 2014 - Barbara Kollmeyer
MannKind: FDA committee recommends Afreeza OK 7:14 a.m. April 2, 2014 - MarketWatch.com
MannKind soars 97% after FDA panel nod for Afrezza 7:14 a.m. April 2, 2014 - Barbara Kollmeyer
Apollo shares slip after revenue falls short 6:54 p.m. April 1, 2014 - Wallace Witkowski
7 gut checks before the stock market's opening bell 6:25 a.m. Aug. 15, 2013 - Shawn Langlois
On a mixed day, two biopharma firms' insulin drugs vie for investors 11:41 a.m. June 19, 2013 - Russ Britt
MannKind shares leap as web site says firm is a ripe takeover target 1:32 p.m. May 22, 2013 - Russ Britt
MannKind up 6.9% in premarket 8:43 a.m. Jan. 2, 2013 - Steve Gelsi
MannKind prices offering at 23% discount 10:04 a.m. Oct. 18, 2012 - MarketWatch.com
MannKind down 25% in premarket 8:59 a.m. Oct. 18, 2012 - Steve Gelsi
MannKind continues its bull run 12:16 p.m. Today - Seeking Alpha
MannKind (MNKD) Surges to 52-Week High as Afrezza Approval Approaches 11:58 a.m. Today - TheStreet.com
Hottest Healthcare Stocks Now – EXAS MNKD KERX MYGN 8:00 a.m. Today - InvestorPlace.com
As Predicted, MannKind Starting Emotionally Fueled Run To FDA Approval, When It May Be Best To Go Short 8:59 a.m. June 3, 2014 - Seeking Alpha
MannKind (MNKD) at Jefferies Global Healthcare Conference (Transcript) 7:25 p.m. June 2, 2014 - Seeking Alpha
MannKind's (MNKD) Management Presents at Jefferies Global Healthcare Conference (Transcript) 7:25 p.m. June 2, 2014 - Seeking Alpha
5 Stocks With Poor Sales Growth — HTS MITT LPCN MNKD UEC 10:00 a.m. June 2, 2014 - InvestorPlace.com
The IBB Likely To Move Higher Along With These Biotechs With Catalysts Upcoming 8:30 a.m. June 2, 2014 - Seeking Alpha
Biggest Movers in Healthcare Stocks Now – MNKD LCI RDY NBIX 7:45 a.m. May 30, 2014 - InvestorPlace.com
The Seven Deadly Sins of Biotech Investing 7:00 a.m. May 29, 2014 - TheStreet.com
Hottest Healthcare Stocks Now – HZNP MNKD BSX ISIS 1:45 p.m. May 28, 2014 - InvestorPlace.com
Short MannKind On Afrezza Approval? 3:33 p.m. May 27, 2014 - Seeking Alpha
MannKind Annual Shareholder Meeting Provides Further Optimism For Afrezza And Technosphere Platform 3:05 p.m. May 27, 2014 - Seeking Alpha
One Small Step For Afrezza, One Huge Step For MannKind? 10:44 a.m. May 27, 2014 - benzinga.com
2nd Half Of 2014 Biotechnology Catalysts: Part 1 9:34 a.m. May 27, 2014 - Seeking Alpha
Biotech Stock Roundup: Celldex, Incyte Tie Up with Big Pharma for Immuno-Oncology - Analyst Blog 9:22 a.m. May 21, 2014 - Zacks.com
Hottest Healthcare Stocks Now – CLVS CYH AZN MNKD 9:00 a.m. May 20, 2014 - InvestorPlace.com
MannKind: Approval For Afrezza Looking More And More Positive As Investors Await FDA Decision 10:03 a.m. May 19, 2014 - Seeking Alpha
Hottest Healthcare Stocks Now – ICLR PRXL MNKD SGEN 6:15 a.m. May 19, 2014 - InvestorPlace.com
Twelve Analyst Stocks to Buy Under $10 for Big Upside 8:35 a.m. May 17, 2014 - 247WallSt.com
MannKind to Present at Upcoming Conferences 9:01 a.m. May 27, 2014 - GlobeNewswire
Reveal Insider Trading for Facebook, MannKind, QUALCOMM, American Realty Capital Properties, salesforce.com, and Symantec 8:55 a.m. May 22, 2014 - PR Newswire - PRF
Technical Data on Top Gainers -- Research on MannKind, Intermolecular, FireEye, and Yingli Green Energy Holding 9:10 a.m. May 20, 2014 - PR Newswire - PRF
Earnings Release Results, and Leadership Appointments - Analyst Notes on Halozyme, MannKind, Arrowhead, Idera and BioCryst 7:00 a.m. May 16, 2014 - PR Newswire - PRF
Critical Alerts For Citigroup, Linn Energy, MannKind, Canadian Solar, and Qualcomm Released By InvestorsObserver 9:31 a.m. May 15, 2014 - PR Newswire - PRF
MannKind Corporation Pending FDA Approval Inspires Analyst Report by BrokerBank Securities, Inc. 8:00 a.m. May 14, 2014 - PR Newswire - PRF
MannKind Corporation Reports 2014 First Quarter Financial Results 9:01 a.m. May 12, 2014 - GlobeNewswire
MannKind to Present at Bank of America Merrill Lynch 2014 Health Care Conference 5:01 p.m. May 7, 2014 - GlobeNewswire
MannKind Corporation to Hold 2014 First Quarter Financial Results Conference Call on May 12, 2014 9:01 a.m. May 5, 2014 - GlobeNewswire
Active Stocks Technical Review -- Research on AES Corp., Baidu, Hertz Global Holdings, and MannKind 1:01 p.m. April 30, 2014 - PR Newswire - PRF
Abattis Bioceuticals Corp. Enters Into Share Agreement with Experion 10:00 a.m. April 17, 2014 - ACCESSWIRE
Elite Pharmaceuticals to Receive up to 40 Million from Lincoln Park Capital Fund 10:01 a.m. April 15, 2014 - ACCESSWIRE
Critical Alerts For Walt Disney, Walgreen, BioMarin Pharmaceuticals, Canadian Solar, and MannKind Released By InvestorsObserver 9:31 a.m. April 14, 2014 - PR Newswire - PRF
FDA Recommendations, Study Publications, Recognitions, Agreements, and Acquisitions - Analyst Notes on MannKind, Acceleron, Steris, Retrophin, and NxStage Medical 8:00 a.m. April 11, 2014 - PR Newswire - PRF
Petr Announces Well Online and Estimates 26,000 Barrels of Oil per Day; MannKind's Afressa Drug Decision Extended by the FDA 1:05 a.m. April 8, 2014 - ACCESSWIRE
MannKind Updates Status of New Drug Application for AFREZZA(R) 4:00 a.m. April 7, 2014 - GlobeNewswire
Pre-Market Review on Top Gainers -- Research on MannKind, ZBB Energy, B2Gold, and DFC Global 9:08 a.m. April 3, 2014 - PR Newswire - PRF
Insider Trading Alert - Free Research of General Motors, Apple, RF Micro Devices, MannKind, Sirius XM, and Plug Power 8:55 a.m. April 3, 2014 - PR Newswire - PRF
FDA Panel Grants Market Approval of MannKind Corp.'s Inhalable Insulin 9:49 a.m. April 2, 2014 - ACCESSWIRE
FDA Advisory Committee Recommends Approval of AFREZZA(R), MannKind Corporation's Investigational Drug to Treat Diabetes 5:47 p.m. April 1, 2014 - GlobeNewswire
(0)
(0)